Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS
· Delayed Price · Currency is USD
0.7500
+0.5300 (240.91%)
At close: Jun 25, 2025
Raphael Pharmaceutical Statistics
Total Valuation
RAPH has a market cap or net worth of 14.72 million. The enterprise value is 14.71 million.
Market Cap | 14.72M |
Enterprise Value | 14.71M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RAPH has 19.63 million shares outstanding. The number of shares has increased by 8.90% in one year.
Current Share Class | 19.63M |
Shares Outstanding | 19.63M |
Shares Change (YoY) | +8.90% |
Shares Change (QoQ) | +4.64% |
Owned by Insiders (%) | 42.32% |
Owned by Institutions (%) | 19.28% |
Float | 11.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -20.05 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -10.52 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -25.90 |
Financial Position
The company has a current ratio of 0.11
Current Ratio | 0.11 |
Quick Ratio | 0.06 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.07 |
Interest Coverage | -1,387.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -388.73% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 188.96% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 2.25 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 47.55 |
Average Volume (20 Days) | 744 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.39M |
Pretax Income | -1.40M |
Net Income | -1.40M |
EBITDA | n/a |
EBIT | -1.39M |
Earnings Per Share (EPS) | -0.07 |
Balance Sheet
The company has 50,000 in cash and 41,000 in debt, giving a net cash position of 9,000 or 0.00 per share.
Cash & Cash Equivalents | 50,000 |
Total Debt | 41,000 |
Net Cash | 9,000 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -734,000 |
Book Value Per Share | -0.04 |
Working Capital | -736,000 |
Cash Flow
In the last 12 months, operating cash flow was -569,000 and capital expenditures 1,000, giving a free cash flow of -568,000.
Operating Cash Flow | -569,000 |
Capital Expenditures | 1,000 |
Free Cash Flow | -568,000 |
FCF Per Share | -0.03 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RAPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.90% |
Shareholder Yield | n/a |
Earnings Yield | -9.50% |
FCF Yield | -3.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |